Navigation Links
U.S. FDA Approves Natazia(TM), a New Oral Contraceptive for the Prevention of Pregnancy
Date:5/6/2010

ghly effective in preventing pregnancy.  The PI calculation was based on criteria established by the FDA (pregnancies that occurred in women aged 18-35 years during cycles 1-13 (including pregnancies 7 days post-treatment).

The most common treatment-emergent adverse reactions (greater than or equal to 2%) were headache (including migraines) (13.2%), metrorrhagia and irregular menstruation (8.0%), breast pain, discomfort or tenderness (6.6%), nausea or vomiting (6.5%), acne (3.9%), and increased weight (2.8%).

For full prescribing information, please visit www.natazia.com or call 1.888.84.BAYER.

About Bayer HealthCare Pharmaceuticals Inc.

Bayer HealthCare Pharmaceuticals Inc. is the U.S.-based pharmaceuticals operation of Bayer HealthCare LLC, a division of Bayer AG.  One of the world's leading, innovative companies in the healthcare and medical products industry, Bayer HealthCare combines the global activities of the Animal Health, Consumer Care, Diabetes Care, and Pharmaceuticals divisions.  In the United States, Bayer HealthCare Pharmaceuticals comprises the following business units: Women's Healthcare, Diagnostic Imaging, General Medicine, Hematology/Neurology, and Oncology.  The company's aim is to discover and manufacture products that will improve human health worldwide by diagnosing, preventing and treating diseases.

This news release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management.  Various known and unknown risks, uncertainties and other factors could lead to material differences
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. FDA Approves New Combination Product Oral Contraceptive
2. FDA Approves Labeling Change for Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII to Include Supplemental Data Demonstrating Significant Efficacy at Two Hours Through 14 Hours After Administration in Adults with ADHD
3. FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
4. FDA Approves New Device for Adults with Severe and Persistent Asthma
5. FDA Approves Drug to Treat Condition That Causes Elevated Ammonia Levels
6. FDA Approves First of Its Kind, Fully Implantable (Surgically), Invisible, Prosthetic Hearing Restoration Device
7. FDA Approves First Totally Implanted Hearing System
8. FDA Approves Watsons TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
9. FDA Approves Name Change for Heartburn Drug Kapidex
10. FDA Approves First Generic Tamsulosin to Treat Enlarged Prostate Gland
11. FDA Approves First New Inhaled Antibiotic for CF in More Than a Decade
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014  A prospective study conducted by ... has validated the performance of VolparaDensity breast ... associated volumetrically assessed breast density measurements to breast ... & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the article, "Automated ... widespread breast cancer risk assessment," was authored by ...
(Date:7/28/2014)... -- Houston dentist , Dr. Behzad Nazari ... Invisalign. With access to this increasingly popular orthodontic ... without feeling self-conscious in the process. Invisalign offers ... of braces, but patients who choose Invisalign over ... support for their oral health and comfort during ...
(Date:7/28/2014)... ORLANDO, Fla. , July 28, 2014 /PRNewswire/ ... "Company"), a biopharmaceutical company focused on the development, ... that it has filed definitive proxy materials with ... its 2014 Annual Meeting of Shareholders to be ... a.m., East Standard Time. The record date for ...
Breaking Medicine Technology:Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4Houston Cosmetic Dentist, Dr. Behzad Nazari, Now Offers Orthodontic Treatment with Invisalign 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 2TNI BioTech, Inc., Files Definitive Proxy Materials; Mails Letter Urging Shareholders to Vote the Proxy Card 3
... Calif., June 04, 2007 /PRNewswire-FirstCall/ -- Kosan,Biosciences ... clinical,trial showing that KOS-1584/R1645, an epothilone under,co-development ... in patients with solid tumors.,KOS-1584/R1645 showed activity ... including activity in patients with non-small cell ...
... Investigational cancer drug Pertuzumab shows promising results ... Phase III,development initiated, BASEL, Switzerland, June 4, ... exciting new cancer medicine pertuzumab, a HER,dimerisation ... pre-treated HER2 positive breast cancer, when,combined with ...
Cached Medicine Technology:Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 2Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 3Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 4Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 5Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 2Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 3Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 4Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 5
(Date:7/28/2014)... TN (PRWEB) July 28, 2014 ... Operation Military June . Renowned LASIK and ... June" to provide significant funds and public awareness ... and retired military personnel and their families. “This ... will proudly give nearly $5,000 to a variety ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Cape ... Summit Provider Exchange technology solution in an ... efforts and support collaboration with their New Jersey ... acute-care medical center located in New Jersey, serves ... visitors with a variety of inpatient and outpatient ...
(Date:7/28/2014)... Maureen Salamon ... News) -- Infants and children who are at risk ... be vaccinated against the infection, according to updated recommendations ... And routine vaccinations for the potentially deadly ... American Academy of Pediatrics says. In its first ...
(Date:7/28/2014)... researchers report that an alternative to the traditional handshake ... experiments, the scientists found that clasping hands transferred about ... other than what is known as a fist bump. ... a cultural substitute for the firm gripping of hands. ... of the American Journal of Infection Control . ...
(Date:7/28/2014)... Reinberg HealthDay Reporter MONDAY, ... and heart rhythm irregularities are more likely to get a ... In fact, the study of more than 16,000 people found ... likely to get a pacemaker than those without the memory-robbing ... why folks with dementia are so much more likely to ...
Breaking Medicine News(10 mins):Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 3Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 2Health News:Pacemakers Common for Those With Dementia and Irregular Heartbeats 3
... MEMPHIS, Tenn., Oct. 21 Sedgwick Claims Management ... compliance services as an in-house, integrated program option ... clients. The Sedgwick CMS Medicare solution includes ... and resolution, and related consulting services. The ...
... , NEW YORK, Oct. 21 The Nielsen Company ... CLIO Awards , one of the world,s most ... of finalists for the first-ever CLIO Healthcare Awards ... Healthcare Awards taking place on November 13 at Skyline ...
... 21, 2009) The International Serious Adverse Events Consortium ... Research Network (HMORN) to improve the safe use of ... individuals makes them more likely to experience serious drug-related ... non-profit international research consortium. The HMORN is the ...
... issues of sexual dysfunction with their patients, according to ... In their article appearing in a November 2009 ... Internal Medicine , now available online, the investigators report ... survey indicated they rarely or never discussed sexual problems ...
... ... the right gift basket., , ... CA (PRWEB) October 21, 2009 -- For all those times when the words ,thank you, ... baskets that send the right message, at the right time and for the right price. ...
... Plastic Surgeons ... ... Surgeons (ASPS) will donate more than 1,500 multi-sport helmets to the children of Seattle in ... held at Leschi Elementary School in Seattle during an assembly in which the children will ...
Cached Medicine News:Health News:Sedgwick CMS Integrates Medicare Compliance Solution With Claims Management Services 2Health News:Nielsen Announces Finalists for the First-Ever CLIO Healthcare Awards 2Health News:Nielsen Announces Finalists for the First-Ever CLIO Healthcare Awards 3Health News:Nielsen Announces Finalists for the First-Ever CLIO Healthcare Awards 4Health News:Nielsen Announces Finalists for the First-Ever CLIO Healthcare Awards 5Health News:Nielsen Announces Finalists for the First-Ever CLIO Healthcare Awards 6Health News:Nielsen Announces Finalists for the First-Ever CLIO Healthcare Awards 7Health News:Nielsen Announces Finalists for the First-Ever CLIO Healthcare Awards 8Health News:Research partnership will study how electronic medical records can address genetics of drug safety 2Health News:Sexual problems rarely addressed by internists caring for cancer survivors 2Health News:Re-define 'Thank-You' With Style and Value From Van's Gifts 2Health News:Seattle Public Schools Get Free “Helmets 4 Safety” 2Health News:Seattle Public Schools Get Free “Helmets 4 Safety” 3Health News:Seattle Public Schools Get Free “Helmets 4 Safety” 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: